EKF has made a $5m seed investment for a 31% stake in Trellus Health, which has licensed a novel digital health platform for the management of Inflammatory Bowel Disease and associated conditions from Mount Sinai Health System. EKF has a partnership with Mt Sinai to commercialise novel technologies, following the successful spin out and IPO of Renalytix in 2018. We make no change to our forecasts at this stage. If successful, we believe Trellus could deliver substantial returns for EKF sharehold ....
20 Aug 2020
$5m investment into Trellus Health
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
$5m investment into Trellus Health
EKF Diagnostics Holdings plc (EKF:LON) | 28.0 0 0.0% | Mkt Cap: 127.0m
- Published:
20 Aug 2020 -
Author:
Chris Glasper -
Pages:
3
EKF has made a $5m seed investment for a 31% stake in Trellus Health, which has licensed a novel digital health platform for the management of Inflammatory Bowel Disease and associated conditions from Mount Sinai Health System. EKF has a partnership with Mt Sinai to commercialise novel technologies, following the successful spin out and IPO of Renalytix in 2018. We make no change to our forecasts at this stage. If successful, we believe Trellus could deliver substantial returns for EKF sharehold ....